1. Home
  2. CMPS vs TSI Comparison

CMPS vs TSI Comparison

Compare CMPS & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • TSI
  • Stock Information
  • Founded
  • CMPS 2020
  • TSI 1987
  • Country
  • CMPS United Kingdom
  • TSI United States
  • Employees
  • CMPS N/A
  • TSI N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • TSI Investment Managers
  • Sector
  • CMPS Health Care
  • TSI Finance
  • Exchange
  • CMPS Nasdaq
  • TSI Nasdaq
  • Market Cap
  • CMPS 364.9M
  • TSI 234.6M
  • IPO Year
  • CMPS 2020
  • TSI N/A
  • Fundamental
  • Price
  • CMPS $4.16
  • TSI $4.93
  • Analyst Decision
  • CMPS Strong Buy
  • TSI
  • Analyst Count
  • CMPS 7
  • TSI 0
  • Target Price
  • CMPS $18.83
  • TSI N/A
  • AVG Volume (30 Days)
  • CMPS 1.0M
  • TSI 106.8K
  • Earning Date
  • CMPS 05-08-2025
  • TSI 01-01-0001
  • Dividend Yield
  • CMPS N/A
  • TSI 7.46%
  • EPS Growth
  • CMPS N/A
  • TSI N/A
  • EPS
  • CMPS N/A
  • TSI N/A
  • Revenue
  • CMPS N/A
  • TSI N/A
  • Revenue This Year
  • CMPS N/A
  • TSI N/A
  • Revenue Next Year
  • CMPS N/A
  • TSI N/A
  • P/E Ratio
  • CMPS N/A
  • TSI N/A
  • Revenue Growth
  • CMPS N/A
  • TSI N/A
  • 52 Week Low
  • CMPS $2.49
  • TSI $4.48
  • 52 Week High
  • CMPS $8.54
  • TSI $4.87
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 55.37
  • TSI 56.87
  • Support Level
  • CMPS $3.86
  • TSI $4.89
  • Resistance Level
  • CMPS $4.52
  • TSI $4.95
  • Average True Range (ATR)
  • CMPS 0.32
  • TSI 0.04
  • MACD
  • CMPS -0.02
  • TSI 0.00
  • Stochastic Oscillator
  • CMPS 32.03
  • TSI 65.00

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About TSI TCW Strategic Income Fund Inc.

Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.

Share on Social Networks: